Dr Will Bernard, Senior Scientist at bit.bio, and Dr Luke Flatt, Senior Scientist at Charles River, 2020, bit.bio
Introducing human iPSC-derived muscle cells for research and drug discovery.
Dr Will Bernard, Senior Scientist at bit.bio, and Dr Luke Flatt, Senior Scientist at Charles River discuss how bit.bio’s iPSC-derived ioSkeletal Myocytes can facilitate HTS workflows and accelerate research into muscle and metabolic disease.
This webinar discusses how bit.bio’s iPSC-derived ioSkeletal Myocytes can facilitate HTS workflows and accelerate research into muscle and metabolic disease and showcases: